|
PL189872B1
(pl)
|
1996-07-24 |
2005-10-31 |
Warner Lambert Co |
Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
|
|
KR100563894B1
(ko)
|
1997-09-18 |
2006-03-24 |
워너-램버트 캄파니 엘엘씨 |
가바펜틴 동족체의 신규 입체선택적 제조 방법
|
|
DE19751062A1
(de)
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
NZ503980A
(en)
*
|
1997-12-16 |
2002-09-27 |
Warner Lambert Co |
4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (= gabapentin analogues), pharmaceuticals thereof, and their use in the treatment of neurological disorders
|
|
JP2003528148A
(ja)
*
|
2000-03-28 |
2003-09-24 |
デロレンゾ、ロバート・ジェイ |
損傷に際して神経細胞中に形成される新規カルシウム損傷電流の阻害は神経細胞死を抑制する
|
|
AU2002230398A1
(en)
|
2000-10-06 |
2002-04-29 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
AU2002211863A1
(en)
|
2000-10-06 |
2002-04-15 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
AU2002345638A1
(en)
|
2001-06-11 |
2002-12-23 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
CA2449729C
(en)
|
2001-06-11 |
2009-11-03 |
Xenoport, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
AU2002316231A1
(en)
|
2002-02-19 |
2003-09-29 |
Xenoport, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
AU2003243180A1
(en)
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
US7060727B2
(en)
|
2002-12-11 |
2006-06-13 |
Xenoport, Inc. |
Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
|
|
AU2003303041B2
(en)
|
2002-12-13 |
2008-07-24 |
Warner-Lambert Company Llc |
Alpha-2-delta ligand to treat lower urinary tract symptoms
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
KR20060119971A
(ko)
|
2003-09-11 |
2006-11-24 |
제노포트 인코포레이티드 |
Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
|
|
AU2004271800A1
(en)
|
2003-09-12 |
2005-03-24 |
Pfizer Inc. |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
NZ579515A
(en)
|
2003-09-17 |
2011-09-30 |
Xenoport Inc |
Treating or preventing restless legs syndrome using prodrugs of gaba analogs
|
|
SG147437A1
(en)
|
2003-10-14 |
2008-11-28 |
Xenoport Inc |
Crystalline form of gamma-aminobutyric acid analog
|
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
|
MX2007005306A
(es)
|
2004-11-04 |
2007-06-11 |
Xenoport Inc |
Formas de dosis oral de liberacion sostenida de la prodroga gabapentina.
|
|
CA2673545A1
(en)
|
2006-12-22 |
2008-07-03 |
Recordati Ireland Limited |
Combination therapy of lower urinary tract disorders with .alpha.2.delta. ligands and nsaids
|
|
WO2009024615A1
(en)
*
|
2007-08-23 |
2009-02-26 |
Novartis Ag |
Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
|
|
EP2250148B1
(en)
|
2008-01-25 |
2016-08-17 |
XenoPort, Inc. |
Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
|
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
ES2601852T3
(es)
|
2008-01-25 |
2017-02-16 |
Xenoport, Inc. |
Forma cristalina de sales de calcio de ácidos (3S)-aminometil-5-metil-hexanoicos y métodos de uso
|
|
ES2589915T3
(es)
|
2008-10-08 |
2016-11-17 |
Xgene Pharmaceutical Inc |
Conjugados de GABA y métodos de utilización de los mismos
|
|
WO2010084797A1
(ja)
*
|
2009-01-21 |
2010-07-29 |
第一三共株式会社 |
含ヘテロ原子化合物
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
CA2903000C
(en)
|
2013-01-28 |
2021-10-12 |
Hector L. Lopez |
Methods of improving tolerability, pharmacodynamics, and efficacy of .beta.-alanine and use therefor
|
|
CA3099775A1
(en)
|
2018-05-14 |
2019-11-21 |
Xgene Pharmaceutical Inc. |
Process for making 1-(acyloxy)-alkyl-carabmate drug conjugates of naproxen and pregabalin
|